Sbir phase II: automated multi-array platform for cancer biomarkers
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200900042C
- Awardee
-
Meso Scale Diagnostics LLC UEI MBWYUNWCFJ58
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $998,408
Award facts
- Opportunity
-
- N44CO9700310 Solicitation number
- Contract value 100% obligated
- $998,408.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- MONTGOMRY VLG, MD 20877, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $998,408 |
About this award
This federal contract award is for a Small Business Innovation Research (SBIR) Phase II project titled "AUTOMATED MULTI-ARRAY PLATFORM FOR CANCER BIOMARKERS", awarded by the National Cancer Institute (NCI) to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. The $998,408 cost-plus-fixed-fee contract was awarded on September 30, 2009 and has a completion date of January 31, 2012. Meso Scale Diagnostics is a small business that specializes in assay development, laboratory testing equipment, and multiplex assays for biomedical research and diagnostics. The company has extensive experience supporting federal agencies through prime contracts, subcontracts, and grants, including work for the Department of Health and Human Services, Department of Defense, and Department of Homeland Security. This SBIR Phase II award reflects the agency's investment in advancing Meso Scale Diagnostics' automated platform for detecting cancer biomarkers, which aligns with NCI's mission to support innovative research and development in cancer-related technologies.
Quick answers
Who was awarded contract HHSN261200900042C?
HHSN261200900042C was awarded to Meso Scale Diagnostics LLC by National Cancer Institute (National Institutes of Health) on September 30, 2009.
How much is contract HHSN261200900042C worth?
The government has obligated $998,408 on HHSN261200900042C.
Was contract HHSN261200900042C competed?
The extent of competition for HHSN261200900042C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award